HI
BSX icon

Horizon Investments’s Boston Scientific BSX Stock Holding History

Horizon Investments’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.11M Sell
49,626
-35,595
-42% -$2.85M 0.03% 376
2025
Q4 		$8.13M Sell
85,221
-11,594
-12% -$1.14M 0.1% 165
2025
Q3 		$9.45M Sell
96,815
-584
-0.6% -$60.5K 0.12% 132
2025
Q2 		$10.5M Buy
97,399
+74,223
+320% +$7.51M 0.17% 101
2025
Q1 		$2.34M Buy
23,176
+1,036
+5% +$104K 0.07% 176
2024
Q4 		$1.98M Buy
22,140
+295
+1% +$26K 0.06% 189
2024
Q3 		$1.83M Sell
21,845
-1,858
-8% -$146K 0.05% 191
2024
Q2 		$1.83M Buy
23,703
+250
+1% +$18.3K 0.05% 177
2024
Q1 		$1.61M Buy
23,453
+1,153
+5% +$74.1K 0.04% 196
2023
Q4 		$1.29M Buy
22,300
+11,307
+103% +$604K 0.04% 200
2023
Q3 		$580K Buy
10,993
+165
+2% +$8.65K 0.02% 258
2023
Q2 		$586K Buy
10,828
+1,796
+20% +$93.8K 0.02% 258
2023
Q1 		$452K Buy
9,032
+2,110
+30% +$99.4K 0.01% 309
2022
Q4 		$320K Buy
+6,922
New +$300K 0.01% 450
2022
Q3 		– Sell
-11,706
Closed -$436K – 483
2022
Q2 		$436K Sell
11,706
-354
-3% -$14.4K 0.01% 308
2022
Q1 		$534K Buy
12,060
+1,861
+18% +$80.7K 0.02% 331
2021
Q4 		$433K Buy
10,199
+863
+9% +$36.3K 0.01% 353
2021
Q3 		$405K Buy
9,336
+409
+5% +$18.1K 0.01% 353
2021
Q2 		$382K Buy
8,927
+235
+3% +$9.89K 0.01% 362
2021
Q1 		$336K Buy
+8,692
New +$329K 0.01% 363
2020
Q4 		– Sell
-9,783
Closed -$374K – 123
2020
Q3 		$374K Sell
9,783
-8,621
-47% -$332K 0.01% 324
2020
Q2 		$646K Buy
18,404
+7,329
+66% +$264K 0.02% 298
2020
Q1 		$361K Buy
11,075
+368
+3% +$14.4K 0.02% 218
2019
Q4 		$484K Buy
10,707
+3,824
+56% +$160K 0.02% 299
2019
Q3 		$280K Buy
+6,883
New +$292K 0.01% 263

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Horizon Investments's BSX Position: Q1 2026 in Review

Horizon Investments reduced its Boston Scientific (BSX) stake by 42% in Q1 2026, selling an estimated $2.85M and leaving 49,626 shares worth $3.11M. The position accounts for 0.03% of the portfolio, ranked #376.

Horizon Investments first reported a position in BSX in Q3 2019 and has held it in 25 quarters since. The position peaked at $10.5M in Q2 2025. 1,671 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Horizon Investments held 49,626 shares of Boston Scientific worth $3.11M as of Q1 2026.
  • Horizon Investments sold 35,595 Boston Scientific shares in Q1 2026, an estimated $2.85M.
  • Boston Scientific made up 0.03% of Horizon Investments's portfolio in Q1 2026, its #376 holding.
  • Horizon Investments first reported a position in Boston Scientific in Q3 2019 and has held it in 25 quarters since.
  • Horizon Investments's Boston Scientific position peaked at $10.5M in Q2 2025.
  • 1,671 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Horizon Investments's 13F filing for Q1 2026, filed 15 May 2026.